AstraZeneca will pay nearly a half-billion dollars to settle cases alleging its popular heartburn drugs damages the kidneys of users. The Cambridge, UK-based pharma giant will be paying $425 ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...

Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn treatments for 425 million US dollars (£352 million). The FTSE 100 listed firm said the agreements will ...

Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn treatments for 425 million US dollars (£352 million). The FTSE 100 listed firm said the agreements will ...

AstraZeneca is calling off two late-stage trials into the potential benefits of its potassium-reduction drug Lokelma in ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is ...